Get the Stockscreener App
1.98
2.06%
0.04
Pre-market:
1.98
Q 32 Bio Inc stock is traded at $1.98, with a volume of 48,472.
It is up +2.06% in the last 24 hours and up +15.79% over the past month.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
See More
Previous Close:
$1.94
Open:
$1.94
24h Volume:
48,472
Relative Volume:
0.04
Market Cap:
$24.15M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+9.39%
1M Performance:
+15.79%
6M Performance:
+20.00%
1Y Performance:
-95.56%
1-Day Range:
$1.9101
$1.98
1-Week Range:
$1.7906
$1.98
52-Week Range:
$1.345
$53.17
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio Inc
Sector
Industry
Phone
781-999-0232
Address
830 WINTER STREET, WALTHAM
Compare QTTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTTB
Q 32 Bio Inc
|
1.98 | 23.66M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Q 32 Bio Inc Stock (QTTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Feb-11-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-11-24 | Downgrade | Guggenheim | Buy → Neutral |
| Dec-11-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | BMO Capital Markets | Outperform |
| Oct-24-24 | Initiated | Raymond James | Strong Buy |
| Sep-11-24 | Initiated | Wells Fargo | Overweight |
| Jun-17-24 | Initiated | Guggenheim | Buy |
| May-21-24 | Initiated | Leerink Partners | Outperform |
| Apr-11-24 | Initiated | Oppenheimer | Outperform |
| Apr-02-24 | Initiated | Piper Sandler | Overweight |
| Jul-28-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-22-22 | Reiterated | BTIG Research | Neutral |
| Feb-22-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-22-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-02-21 | Initiated | Stifel | Hold |
| Dec-14-20 | Resumed | H.C. Wainwright | Buy |
| Aug-11-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| Mar-16-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Feb-24-20 | Initiated | Chardan Capital Markets | Buy |
| Nov-01-19 | Initiated | Oppenheimer | Perform |
| Sep-10-19 | Initiated | Robert W. Baird | Outperform |
| Apr-12-19 | Initiated | Evercore ISI | Outperform |
View All
Q 32 Bio Inc Stock (QTTB) Latest News
Goldman Sachs Group Inc. Boosts Stake in Q32 Bio Inc. $QTTB - Defense World
How to forecast Q32 Bio Inc. trends using time seriesOil Prices & Risk Managed Investment Signals - newser.com
Applying Elliott Wave Theory to Q32 Bio Inc.2025 Price Momentum & Fast Exit Strategy with Risk Control - newser.com
Relative strength of Q32 Bio Inc. in sector analysis2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com
What MACD and RSI say about Q32 Bio Inc.2025 Earnings Impact & Technical Entry and Exit Tips - newser.com
Will Q32 Bio Inc. stock split again soon2025 Retail Activity & High Return Stock Watch Alerts - newser.com
What drives Q32 Bio Inc stock priceCapital Gains Strategies & Low Entry Risk Stocks - earlytimes.in
Why Q32 Bio Inc. is moving today2025 Sector Review & Smart Investment Allocation Insights - newser.com
Q32 Bio Inc Stock Analysis and ForecastGap Fill Strategies & Superior Portfolio Investment - earlytimes.in
Detecting price anomalies in Q32 Bio Inc. with AIMarket Sentiment Summary & Weekly Momentum Stock Picks - newser.com
Visual analytics tools that track Q32 Bio Inc. performanceTrade Analysis Report & Reliable Entry Point Trade Alerts - newser.com
Will Q32 Bio Inc. stock recover after recent dropQuarterly Portfolio Review & AI Driven Price Predictions - newser.com
Fundamentals Check: Will Q32 Bio Inc stock benefit from M AJuly 2025 Spike Watch & Daily Stock Trend Reports - خودرو بانک
Aug Ideas: Will EUDA Health Holdings Limited benefit from rate cutsJuly 2025 Levels & Daily Profit Focused Stock Screening - خودرو بانک
Can you recover from losses in Q32 Bio Inc.July 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com
Chart based exit strategy for Q32 Bio Inc.Dollar Strength & Community Supported Trade Ideas - newser.com
What to do if you’re stuck in Q32 Bio Inc.Quarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com
Statistical indicators supporting Q32 Bio Inc.’s strengthJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com
Short interest data insights for Q32 Bio Inc.Portfolio Value Report & Free Weekly Watchlist of Top Performers - newser.com
Is this a good reentry point in Q32 Bio Inc.Stop Loss & Momentum Based Trading Signals - newser.com
Backtesting results for Q32 Bio Inc. trading strategiesTrend Reversal & Reliable Volume Spike Alerts - newser.com
Chart overlay techniques for tracking Q32 Bio Inc.Day Trade & Daily Profit Maximizing Tips - newser.com
Earnings Risk: Is Q32 Bio Inc. exposed to currency risksJuly 2025 WrapUp & Weekly Stock Breakout Alerts - خودرو بانک
Aug Wrap: Does Viemed Healthcare Inc stock benefit from AI growth2025 Top Decliners & Accurate Technical Buy Alerts - khodrobank.com
Institutional scanner results for Q32 Bio Inc.Global Markets & Real-Time Stock Entry Alerts - newser.com
Is Q32 Bio Inc. forming a bottoming baseMarket Performance Summary & Fast Exit and Entry Strategy Plans - newser.com
Analyzing Q32 Bio Inc. with multi timeframe charts2025 Key Highlights & Capital Protection Trading Alerts - newser.com
Is now a turning point for Q32 Bio Inc.Sell Signal & Community Consensus Trade Alerts - newser.com
Q32 Bio Inc.’s Promising Alopecia Areata Treatment Trial Update - MSN
Aug Macro: How much upside does Q32 Bio Inc. haveJuly 2025 Breakouts & Community Driven Trade Alerts - خودرو بانک
Quarterly Recap: Does Q32 Bio Inc have declining or rising EPSWeekly Trade Recap & Low Risk Entry Point Guides - خودرو بانک
Portfolio Shifts: Is Q32 Bio Inc exposed to currency risksJuly 2025 Opening Moves & Target Return Focused Stock Picks - خودرو بانک
Aug EndMonth: Can Q32 Bio Inc. lead its sector in growthEarnings Recap Summary & Verified Entry Point Signals - خودرو بانک
Q 32 Bio Inc Stock (QTTB) Financials Data
There is no financial data for Q 32 Bio Inc (QTTB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):